WEBCAST

WEBCAST Tuesday, March 28th, 2017 at 14:30 pm CET/08:30 am EDT


ERYTECH will hold a conference call and webcast on Tuesday, March 28th at 2:30 pm CET / 8:30 am EDT, to discuss the results of its Phase 2b clinical study.


Investors and analysts wishing to participate can access the call via the following teleconferencing numbers

USA: +1 6467224907
United-Kingdom: +44 2030432440
Switzerland: +41 225809022
Germany: +49 69222229031
France: +33 172001510
Belgium: +32 24029640
Sweden: +46 850334664
Finland: +358 942599700
Netherlands: +31 107138194


Confirmation Code: 43037159#


The webcast can be followed live online via the link

http://www.anywhereconference.com?UserAudioMode=DATA&Name=&Conference=135307755&PIN=43037159

Following the live call, a replay will be available for 90 days. To listen to the replay, please dial:
USA: +1 877 64 230 18
United-Kingdom: +44 20 33 67 94 60
France: +33 1 72 00 15 00

Confirmation Code: 307755#

Link to slideshow

Top